1. Home
  2. BNR vs GLO Comparison

BNR vs GLO Comparison

Compare BNR & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.02

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Logo Clough Global Opportunities Fund

GLO

Clough Global Opportunities Fund

HOLD

Current Price

$6.02

Market Cap

242.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
GLO
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
179.7M
242.9M
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
BNR
GLO
Price
$9.02
$6.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.1K
182.5K
Earning Date
06-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$5.20
52 Week High
$41.72
$6.09

Technical Indicators

Market Signals
Indicator
BNR
GLO
Relative Strength Index (RSI) 20.79 59.81
Support Level $7.99 $5.88
Resistance Level $9.70 $6.08
Average True Range (ATR) 1.17 0.08
MACD -0.72 0.00
Stochastic Oscillator 2.40 85.00

Price Performance

Historical Comparison
BNR
GLO

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About GLO Clough Global Opportunities Fund

Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.

Share on Social Networks: